A Life-Saving Shift in Rural South Africa
Across rural Africa, a quiet revolution is taking place, one that’s saving lives and strengthening communities.
Technology with a Mother’s touch
HemoClear BV and Nigeria’s National Blood Service Agency (NBSA) are tackling blood scarcity with a breakthrough autologous transfusion technology, aimed at improving care for women during childbirth.
Cell Salvage process optimization drives quality
An analysis of 238 centrifugal cell salvage procedures (154 men, 84 women) demonstrated that quality control benchmarks were consistently achieved, reinforcing the reliability of autologous transfusion in surgical care.
Advancing Intraoperative Blood Management in Spine Surgery
In Adult Spine Deformity (ASD) surgery, where intraoperative blood loss is often significant, cell salvage plays a critical role in reducing reliance on allogenic transfusions and improving perioperative outcomes.
Can safe and efficient blood recovery be achieved during C-sections in low-resource settings?
A newly published study in the International Journal of Gynecology & Obstetrics offers a resounding yes.
Researchers evaluated the HemoClear microfiltration system in cesarean sections at a South African tertiary hospital, and the results are compelling.
HemoClear aligns with all five strategic goals of the EU’s Stockpiling and Medical Countermeasures Strategies, directly supporting Europe’s crisis readiness and health security.
Threat Intelligence & Early Response
Our equipment and electricity free autologous blood transfusion solution enhances clinical resilience in disaster zones and outbreak scenarios.
Join us at the Combat Medical Care Conference 2025 in Ulm, Germany.
HemoClear is proud to participate in the SOF Workshop on July 1st, held on the occasion of the 2025 Combat Medical Care Conference, the international symposium on Tactical Combat Casualty Care for medics, EMTs, paramedics, nurses, and physicians operating in military and law enforcement missions.
New Publication Alert
In a recently published case report, we explore the successful treatment of myasthenia gravis (MG) following long COVID in a 71-year-old patient, using HemoClear gravity-driven plasma exchange.
What if patients didn’t have to rely on others for life-saving blood?
With breakthrough cell salvage technology like HemoClear, patients can receive their own freshly micro-filtered blood, right in the OR or recovery room. No machines, no electricity, no donor blood needed.
Cell salvage reduces transfusions in complex scoliosis surgeries. What if you had access to that capability with greater flexibility and ease?
HemoClear is a breakthrough micro-filtration system that enables high-quality, gravity-driven cell salvage, without the need for machines or electricity. Designed for simplicity, mobility, and performance in the OR.
